Developing variant-adapted COVID-19 vaccines to improve protection against Omicron and other recent variants: a plain language summary
What are variant-adapted COVID-19 vaccines?The COVID-19 vaccine developed by BioNTech and Pfizer is known as BNT162b2 (Comirnaty). BNT162b2 contains messenger RNA, or mRNA, from SARS-CoV-2. SARS-CoV-2 is the virus responsible for COVID-19. mRNA is a type of genetic material that contains the instruc...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis Group
2024-12-01
|
| Edice: | Expert Review of Vaccines |
| Témata: | |
| On-line přístup: | https://www.tandfonline.com/doi/10.1080/14760584.2024.2320858 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
